Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer
靶向激活的 PI3K/mTOR 信号可克服激素受体阳性乳腺癌临床前模型中对基于 CDK4/6 的疗法的获得性耐药性
期刊:Breast Cancer Research
影响因子:6.1
doi:10.1186/s13058-020-01320-8
Neil A O'Brien, Martina S J McDermott, Dylan Conklin, Tong Luo, Raul Ayala, Suruchi Salgar, Kevin Chau, Emmanuelle DiTomaso, Naveen Babbar, Faye Su, Alex Gaither, Sara A Hurvitz, Ronald Linnartz, Kristine Rose, Samit Hirawat, Dennis J Slamon